These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 14520385)
21. Biotech industry faces new bottleneck. Garber K Nat Biotechnol; 2001 Mar; 19(3):184-5. PubMed ID: 11231516 [No Abstract] [Full Text] [Related]
22. Financing nursing home construction 1984 and beyond. Banton JR Nurs Homes; 1983; 32(3):22-5. PubMed ID: 10283916 [No Abstract] [Full Text] [Related]
23. Construction-budget control depends on communication. Johnson PG Health Facil Manage; 1990 Aug; 3(8):12, 14, 16-9. PubMed ID: 10106862 [No Abstract] [Full Text] [Related]
24. Financing healthcare: soaring rates force new strategies. Yanish DL Mod Healthc; 1980 Mar; 10(3):40-1. PubMed ID: 10245571 [No Abstract] [Full Text] [Related]
25. Delisting threat looms large on biotech front. Lawrence S Nat Biotechnol; 2005 Jan; 23(1):5. PubMed ID: 15637598 [No Abstract] [Full Text] [Related]
26. Planning and controlling capital improvement programs. Johnson T J Am Health Care Assoc; 1976 May; 2(3):40-1. PubMed ID: 10621657 [No Abstract] [Full Text] [Related]
27. Capital financing: tax-exempt bonds still lead the way. Oviatt W; Pearson DC Hospitals; 1978 Apr; 52(7):62-5. PubMed ID: 631781 [No Abstract] [Full Text] [Related]
33. Marketing biotechnology with a Gallic flair. Jouanneau AC Nat Biotechnol; 2003 Jul; 21 Suppl():BE36-7. PubMed ID: 12874977 [No Abstract] [Full Text] [Related]
34. Planning for nursing home construction. Beich J J Am Health Care Assoc; 1980 Mar; 6(2):15-22. PubMed ID: 10248068 [No Abstract] [Full Text] [Related]
35. Design & construction. HUD financing program gives hospitals access to much-needed capital. Haugh R Hosp Health Netw; 2009 Jun; 83(6):20, 22. PubMed ID: 19610189 [No Abstract] [Full Text] [Related]
36. Biotechnology financing dilemmas and the role of special purpose entities. Schiff L; Murray F Nat Biotechnol; 2004 Mar; 22(3):271-7. PubMed ID: 14990945 [No Abstract] [Full Text] [Related]
37. Paring down the company: the effect of consolidation in the European biotech sector. Bassett P Nat Biotechnol; 2003 Jul; 21(7):829-30. PubMed ID: 12833105 [No Abstract] [Full Text] [Related]
38. Who took the tech out of biotech? Silverman E Nat Biotechnol; 2006 Mar; 24(3):255-6. PubMed ID: 16525373 [No Abstract] [Full Text] [Related]
39. Need financing for your hospital? Here are some guidelines to follow. Fogarty J Rev Fed Am Hosp; 1976 Dec; 9(6):49-51. PubMed ID: 10242572 [No Abstract] [Full Text] [Related]